Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 5.35B | 5.30B | 5.55B | 5.36B | 5.42B | 5.04B |
Gross Profit | 1.54B | 1.48B | 1.70B | 1.51B | 1.52B | 1.21B |
EBITDA | 1.03B | 890.85M | 1.08B | 963.38M | 1.58B | 1.31B |
Net Income | 595.29M | 581.34M | 741.35M | 694.01M | 718.33M | 576.74M |
Balance Sheet | ||||||
Total Assets | 6.34B | 6.68B | 9.91B | 9.28B | 8.95B | 8.24B |
Cash, Cash Equivalents and Short-Term Investments | 1.54B | 1.76B | 4.62B | 2.26B | 2.07B | 1.49B |
Total Debt | 2.50B | 2.50B | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 3.58B | 3.76B | 1.39B | 1.26B | 1.38B | 1.16B |
Stockholders Equity | 2.76B | 2.92B | 8.52B | 8.02B | 7.57B | 7.08B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 826.04M | 1.05B | 847.29M | 990.93M | 709.56M |
Operating Cash Flow | 0.00 | 837.03M | 1.44B | 1.16B | 1.39B | 1.08B |
Investing Cash Flow | 0.00 | 1.26B | -416.19M | -523.34M | -685.53M | -752.42M |
Financing Cash Flow | 0.00 | -3.68B | -247.95M | -239.25M | -230.93M | -231.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥2.05T | 33.82 | 34.24% | 1.17% | 8.31% | 8.39% | |
76 Outperform | ¥11.45B | 10.77 | 3.24% | -4.45% | 46.54% | ||
76 Outperform | ¥11.01B | 18.73 | 1.22% | ― | ― | ||
73 Outperform | ¥20.22B | 33.10 | 2.25% | 2.47% | 255.70% | ||
70 Outperform | ¥1.09T | 19.27 | 16.17% | 4.20% | 15.49% | 18.42% | |
69 Neutral | ¥230.42B | 14.65 | 7.50% | 2.61% | 9.34% | 5.75% | |
40 Underperform | ¥30.93B | 81.36 | ― | 11.98% | -168.68% |